What Is a False Negative Sentinel Node Biopsy: Definition, Reasons and Ways to Minimize It?
Overview
Affiliations
Sentinel node biopsy helps in assessing the involvement of axillary lymph node without the morbidity of full axillary lymph node dissection, namely arm and shoulder pain, paraesthesia and lymphoedema. The various methods described in the literature identify the sentinel lymph nodes in approximately 96 % of cases and associated with a false negativity rate of 5 to 10 %. A is defined as the proportion of cases in whom sentinel node biopsy is reported as negative, but the harbours cancer cells. The possible causes of a false negative sentinel lymph node may be because of blocked lymphatics either by cancer cells or following fibrosis of previous surgery/radiotherapy, and an alternative pathway opens draining the blue dye or isotope to another . The other reasons may be two lymphatic pathways for a tumour area, the one opening to a superficial node and the other in deep nodes. Sometimes, lymphatics do not relay into a node but traverse it going to a higher node. In some patients, the microscopic focus of metastasis inside a lymph node is so small-micrometastasis (i.e. between 0.2 and 2 mm) or isolated tumour cells (i.e. less than 0.2 mm) that is missed by the pathologist. The purpose of this review is to clear some fears lurking in the mind of most surgeons about the false negative sentinel lymph node (FNSLN).
Real-World Implications of the SOUND Trial.
Giannakou A, Kantor O, Park K, Waks A, Punglia R, Dominici L Ann Surg Oncol. 2024; 31(13):8776-8785.
PMID: 39402322 DOI: 10.1245/s10434-024-16354-x.
Polat D, Nguyen S, Karbasi P, Hulsey K, Cobanoglu M, Wang L Radiol Imaging Cancer. 2024; 6(3):e230107.
PMID: 38607282 PMC: 11148663. DOI: 10.1148/rycan.230107.
Shiomi S, Yagi K, Iwata R, Yajima S, Okumura Y, Aikou S Surg Endosc. 2023; 37(11):8214-8226.
PMID: 37653159 PMC: 10615981. DOI: 10.1007/s00464-023-10368-4.
Role of Sentinel Lymph Node Biopsy for Skin Cancer Based on Clinical Studies.
Ishizuki S, Nakamura Y Cancers (Basel). 2023; 15(13).
PMID: 37444401 PMC: 10340327. DOI: 10.3390/cancers15133291.
Who Needs Level III Lymph Node Dissection in Carcinoma Breast-Study from a Tertiary Care Center.
Suresh G, Yeshwanth R, Arjunan R, Ramachandra C, Altaf S Indian J Surg Oncol. 2023; 14(2):324-330.
PMID: 37324309 PMC: 10267033. DOI: 10.1007/s13193-020-01243-y.